Gastrointestinal dysmotility in the ICU
Anant Vikram Pachisia1, Divya Pal, Deepak Govil
1Institute of Critical Care and Anesthesiology, Medanta-The Medicity, Gurugram, Haryana, India.
Current Opinion in Critical Care
|February 24, 2025
Summary
Gastrointestinal dysmotility affects up to 60% of ICU patients, increasing complications. Early enteral feeding and addressing electrolyte imbalances are key, though prokinetic agents
Area of Science:
- Critical care medicine
- Gastroenterology
- Physiology
Background:
- Gastrointestinal dysmotility is a common complication in critically ill patients.
- Conditions include oesophageal dysmotility, gastroparesis, ileus, and Ogilvie's syndrome.
- Mechanical ventilation increases the risk of gastrointestinal dysmotility.
Purpose of the Study:
- To provide a comprehensive overview of gastrointestinal dysmotility in ICU patients.
- To highlight pathophysiology, prevalence, and clinical implications.
- To examine current diagnostic and treatment approaches.
Main Methods:
- Literature review of recent studies on gastrointestinal dysmotility in critically ill patients.
- Analysis of contributing factors, including inflammation, electrolyte imbalances, and medications.
- Evaluation of nonpharmacological and pharmacological treatment strategies.
Main Results:
- Up to 60% of ICU patients experience gastrointestinal dysmotility.
- Key contributors include inflammatory states, electrolyte imbalances, and medications.
- Nonpharmacological strategies (early enteral feeding, mobilization) are critical; prokinetic agents show promise for feeding intolerance but lack conclusive mortality data.
Conclusions:
- Gastrointestinal dysmotility significantly challenges ICU patient recovery.
- Effective diagnosis and management are essential for improving patient outcomes.
- Further research is needed to optimize care for ICU patients with motility disorders.
Related Concept Videos
01:20Gastrointestinal Motility Disorders
240
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
240
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
234
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
234
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
170
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
170
01:20Drugs Affecting GI Tract Motility: Other Laxatives
159
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
159
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
176
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
176
01:26Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
37
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
37